AstraZeneca Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2001
Cash & Equivalents	5,840	6,166	6,329	7,832	5,369	4,831	3,324	5,018	6,240	6,360	Upgrade
Short-Term Investments	122	239	69	160	849	849	1,230	884	613	795	Upgrade
Cash & Cash Equivalents	5,962	6,405	6,398	7,992	6,218	5,680	4,554	5,902	6,853	7,155	Upgrade
Cash Growth	-6.92%	0.11%	-19.94%	28.53%	9.47%	24.73%	-22.84%	-13.88%	-4.22%	-28.54%	Upgrade
Receivables	12,929	11,356	10,539	7,742	6,501	6,089	5,856	5,474	7,529	8,344	Upgrade
Inventory	5,424	4,699	8,983	4,024	3,193	2,890	3,035	2,334	2,143	1,960	Upgrade
Other Current Assets	739	133	324	-214	-349	932	-295	-448	-518	-762	Upgrade
Total Current Assets	25,054	22,593	26,244	19,544	15,563	15,591	13,150	13,262	16,007	16,697	Upgrade
Property, Plant & Equipment	10,502	9,449	10,171	8,917	8,335	7,421	7,615	6,848	6,413	6,010	Upgrade
Long-Term Investments	1,677	1,142	1,237	1,147	1,459	922	1,036	826	543	561	Upgrade
Goodwill and Intangibles	58,137	59,127	62,489	32,792	32,501	33,666	38,013	39,244	34,446	32,531	Upgrade
Other Long-Term Assets	5,749	4,172	5,222	4,329	3,519	3,051	3,540	2,346	2,647	2,796	Upgrade
Total Long-Term Assets	76,065	73,890	79,119	47,185	45,814	45,060	50,204	49,264	44,049	41,898	Upgrade
Total Assets	101,119	96,483	105,363	66,729	61,377	60,651	63,354	62,526	60,056	58,595	Upgrade
Accounts Payable	25,034	23,310	23,871	21,869	20,278	19,611	19,481	19,974	19,120	19,877	Upgrade
Current Debt	5,400	5,542	1,893	2,386	2,010	1,754	2,247	2,307	916	2,446	Upgrade
Other Current Liabilities	108	-2,559	-3,170	-3,948	-4,171	-5,073	-5,345	-7,025	-5,167	-4,993	Upgrade
Total Current Liabilities	30,542	26,293	22,594	20,307	18,117	16,292	16,383	15,256	14,869	17,330	Upgrade
Long-Term Debt	23,222	23,690	28,888	17,994	16,217	17,359	15,560	14,501	14,137	8,397	Upgrade
Other Long-Term Liabilities	8,189	9,442	14,594	12,790	12,447	12,956	14,769	16,100	12,541	13,222	Upgrade
Total Long-Term Liabilities	31,411	33,132	43,482	30,784	28,664	30,315	30,329	30,601	26,678	21,619	Upgrade
Total Liabilities	61,953	59,425	66,076	51,091	46,781	46,607	46,712	45,857	41,547	38,949	Upgrade
Total Debt	28,622	29,232	30,781	20,380	18,227	19,113	17,807	16,808	15,053	10,843	Upgrade
Debt Growth	-2.09%	-5.03%	51.04%	11.81%	-4.64%	7.33%	5.94%	11.66%	38.83%	4.50%	Upgrade
Retained Earnings	1,502	-574	1,710	5,299	2,812	5,683	8,221	8,140	11,834	13,029	Upgrade
Shareholders' Equity	39,143	37,037	39,268	15,622	13,127	12,468	14,960	14,854	18,490	19,627	Upgrade
Net Cash / Debt	-22,660	-22,827	-24,383	-12,388	-12,009	-13,433	-13,253	-10,906	-8,200	-3,688	Upgrade
Net Cash Per Share	-14.51	-14.63	-17.09	-9.43	-9.23	-10.60	-10.46	-8.61	-6.48	-2.92	Upgrade
Working Capital	-5,488	-3,700	3,650	-763	-2,554	-701	-3,233	-1,994	1,138	-633	Upgrade
Book Value Per Share	12.63	11.96	13.85	5.95	5.04	4.92	5.91	5.87	7.31	7.78	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).